← Insider buys
TCON

Tracon Pharmaceuticals, Inc.

Opaleye Management Inc. bought $67K of Tracon Pharmaceuticals, Inc.

10% owner

Bought$66,846
$2.46Price
27,198Shares
+1%Stake

What TCON did for a copier

Prices for TCON after this filing aren't in yet.

Opaleye Management Inc.'s record

63 other buys with 3 months of prices since 2016: on average +20.3% against the S&P 500, and 33 of 63 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Mon, Apr 11. Filed Tue, Apr 12, 7:38 PM ET, after the close. Not investment advice.